These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 19267332

  • 1. Therapy with GAD in diabetes.
    Ludvigsson J.
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [Abstract] [Full Text] [Related]

  • 2. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW.
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [Abstract] [Full Text] [Related]

  • 3. GAD-alum immunotherapy in Type 1 diabetes mellitus.
    Morales AE, Thrailkill KM.
    Immunotherapy; 2011 Mar; 3(3):323-32. PubMed ID: 21395375
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulation with human recombinant autoantigens.
    Lernmark A, Agardh CD.
    Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
    [Abstract] [Full Text] [Related]

  • 5. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
    Mandrup-Poulsen TR.
    Ugeskr Laeger; 2007 Jan 22; 169(4):300-4. PubMed ID: 17274923
    [Abstract] [Full Text] [Related]

  • 6. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK, Vaarala O, Thuswaldner S, Ilonen J, Hinkkanen A, Ludvigsson J.
    Diabetes Metab Res Rev; 2006 Jan 22; 22(6):462-70. PubMed ID: 16572494
    [Abstract] [Full Text] [Related]

  • 7. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
    Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P.
    Diabetes Care; 2014 Jun 22; 37(6):1675-80. PubMed ID: 24598244
    [Abstract] [Full Text] [Related]

  • 8. Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes.
    Kanazawa Y, Shimada A, Oikawa Y, Okubo Y, Tada A, Imai T, Miyazaki J, Itoh H.
    J Autoimmun; 2009 Mar 22; 32(2):104-9. PubMed ID: 19188044
    [Abstract] [Full Text] [Related]

  • 9. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
    Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T, Pozzilli P, Robert JJ, Veeze HJ, Palmer J, Samuelsson U, Elding Larsson H, Åman J, Kärdell G, Neiderud Helsingborg J, Lundström G, Albinsson E, Carlsson A, Nordvall M, Fors H, Arvidsson CG, Edvardson S, Hanås R, Larsson K, Rathsman B, Forsgren H, Desaix H, Forsander G, Nilsson NÖ, Åkesson CG, Keskinen P, Veijola R, Talvitie T, Raile K, Kapellen T, Burger W, Neu A, Engelsberger I, Heidtmann B, Bechtold S, Leslie D, Chiarelli F, Cicognani A, Chiumello G, Cerutti F, Zuccotti GV, Gomez Gila A, Rica I, Barrio R, Clemente M, López Garcia MJ, Rodriguez M, Gonzalez I, Lopez JP, Oyarzabal M, Reeser HM, Nuboer R, Stouthart P, Bratina N, Bratanic N, de Kerdanet M, Weill J, Ser N, Barat P, Bertrand AM, Carel JC, Reynaud R, Coutant R, Baron S.
    N Engl J Med; 2012 Feb 02; 366(5):433-42. PubMed ID: 22296077
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M, Clark A.
    Diabet Med; 2008 Aug 02; 25 Suppl 2():30-4. PubMed ID: 18717976
    [Abstract] [Full Text] [Related]

  • 11. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
    Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.
    J Exp Med; 2003 Jun 16; 197(12):1635-44. PubMed ID: 12796471
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.
    Elding Larsson H, Lundgren M, Jonsdottir B, Cuthbertson D, Krischer J, DiAPREV-IT Study Group.
    Pediatr Diabetes; 2018 May 16; 19(3):410-419. PubMed ID: 29171140
    [Abstract] [Full Text] [Related]

  • 13. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
    Boettler T, Pagni PP, Jaffe R, Cheng Y, Zerhouni P, von Herrath M.
    J Autoimmun; 2013 Aug 16; 44():40-8. PubMed ID: 23770292
    [Abstract] [Full Text] [Related]

  • 14. Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65).
    Axelsson S, Hjorth M, Akerman L, Ludvigsson J, Casas R.
    Diabetes Metab Res Rev; 2010 Oct 16; 26(7):559-68. PubMed ID: 20830731
    [Abstract] [Full Text] [Related]

  • 15. GAD-alum (Diamyd)--a new concept for preservation of residual insulin secretion.
    Ludvigsson J.
    Expert Opin Biol Ther; 2010 May 16; 10(5):787-99. PubMed ID: 20230187
    [Abstract] [Full Text] [Related]

  • 16. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
    Joussemet B, Vu AT, Sai P, Bach JM.
    Ann N Y Acad Sci; 2005 Jun 16; 1051():613-25. PubMed ID: 16127002
    [Abstract] [Full Text] [Related]

  • 17. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.
    Diabetes; 2008 May 16; 57(5):1321-30. PubMed ID: 18299317
    [Abstract] [Full Text] [Related]

  • 18. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
    Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP.
    Diabetes Res Clin Pract; 2007 Aug 16; 77(2):237-44. PubMed ID: 17234296
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE, Kusters GC, Netea MG, Netten PM.
    Neth J Med; 2006 Apr 16; 64(4):114-8. PubMed ID: 16609158
    [Abstract] [Full Text] [Related]

  • 20. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch, Jamoussi Kamoun H, Trabelsi N, Blouza Chabchoub S.
    Tunis Med; 2008 Apr 16; 86(4):316-8. PubMed ID: 19476130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.